Replies to post #189965 on Biotech Values

[DewDiligence]

The proportion of patients with a VA gain of >=3 lines (15 letters) is the most common primary endpoint in wet AMD. The mean gain in VA is less often used; I can't recall a recent trial in which that was the primary endpoint.